Fact CheckerSign in

NCT04959604Recruiting

Lymph Node Mapping Via Flourescent Dye in Colon Cancer

Lymph Node Mapping Via the Flourescent Dye ICG in Colon Cancer Through Preoperative Application

Source: ClinicalTrials.gov · Last updated 23 May 2023 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green. The aim of the study is to evaluate whether lymph nodes draining the region of the carcinoma are located only inside the lines of standard resection or in some percentages are located outside as well. The visualized nodes draining the region of the carcinoma will be correlated to location, fluorescent yes/no and nodal positive/negative. The draining lymph nodes will be visualized using the fluorescent dye indocyanine green.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
30 Jun 2021
Start date
31 May 2021
Primary completion date
31 Dec 2025
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
NCT number
NCT04959604

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 31 May 2021 to the primary completion date, 31 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • not wanting to participate
  • other carcinoma then adenocarcinoma
  • endoscopic marking not possible

Who the study is looking for

  • histologically diagnosed carcinoma of the ascending, transverse, descending or sigmoid colon.

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Hamburg Medical Institutions
Coordinator of this site? Confirm its status
HamburgGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.